Strides Arcolab to acquire seven brands from Johnson & Johnson

23 Oct 2015 Evaluate

Strides Arcolab has entered into agreements for two independent transactions, which will strengthen the India branded business. The first agreement is for acquisition of seven brands from Johnson & Johnson. The products include across Dermatology, Antiemetic and Pain Management segments, to be launched immediately. The brand portfolio also includes Otogesic eardrops, Ethnorub ointment and Stugil tablets.

The second agreement is for acquisition of majority stake in domestic branded business of Medispan. This will help gain entry into niche Probiotics segment. The brand portfolio includes established brands such as Lactovit and Lactogut. The business in its entirety (including IPs and manpower) will be transferred to an SPV, Strides Biologix, in which Strides will hold 51%.

The acquired portfolios have a combined revenue potential of Rs 32 crore in FY 2015-16. The above transactions are subject to statutory approval and other customary closing conditions.



Strides Pharma Scien Share Price

862.85 -15.80 (-1.80%)
08-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1267.15
Cipla 1497.45
Zydus Lifesciences 924.35
Lupin 2071.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×